As the company prepares to sell the medical marijuana, it follows two sets of regulations for the sale of its products next month, a state law passed only 18-months ago and an even older edict of Torah.

A New York dispensary will offer kosher certified marijuana starting in January. Vireo Health of New York, one of the five companies permitted to grow the cannabis, has received their certification from the Orthodox Union (OU).

Ari Hoffnug, the CEO of Vireo Health tells Medical Daily that he thinks this is a step in right direction to combat the stigma associated with medical cannabis. “It is our hope that having the OU certification will help to send a message to all faiths and  backgrounds. That if you need to use medical marijuana you shouldn’t feel guilty or shamed,” said Hoffnug.

With marijuana now legal in some form throughout 23 states, the number of Americans who fatally overdosed on the drug last year was significant:

In July 2014, five companies were awarded licenses by the New York State Health Department to grow and sell marijuana in the state, and in New York City. One of them, a Minneapolis-based company called Vireo Health, which produces “pharmaceutical-grade cannabis-derived medicine,” announced Wednesday that all of its products had received kosher certification from the Orthodox Union.

California Assemblyman Rob Bonta played a critical function in pressing through policies on the state’s medical marijuana industry, which will significantly change the nation’s biggest MMJ market.

Bonta was a main sponsor of Assembly Costs 266, among three procedures known jointly as the Medical Marijuana Regulation and Security Act (MMRSA).

Geena’s struggling with arthritis pain and wants to know if medical marijuana (cannabis) will provide relief that she’s desperate for.

Watch to find out what Dr. Patel has to say about current research on medical marijuana (cannabis) and arthritis and hear about the results she’s seen in her own patients struggling with arthritis pain.

Considering using medical marijuana (cannabis) for your arthritis pain? See Dr. Patel at her medical marijuana (cannabis) clinic today! Visit www.DrRachnaPatel.com to schedule your evaluation for a medical marijuana (cannabis) card!

Dr. Rachna Patel
The Medical Marijuana (Cannabis) Expert

At this rate, I think it will have taken Florida longer than any other state to implement one, single, medical marijuana law. Since being signed into law in 2014 we’ve continuously hit one hold up after another – and just when it feels like we’re finally picking up momentum and getting somewhere, things come to a screeching halt.

After the five allotted nurseries were selected at the end of November it seemed that we may finally see patients getting relief early in 2016. Hopes for that might have been too high, however, because a total of 11 different companies have challenged the Department of Health’s ruling on the matter.

On Monday, New Hampshire began issuing the ID cards for qualifying patients to buy medicinal marijuana, ABC affiliate station WMUR-9 reported. Though the state Legislature legalized medicinal cannabis in 2013, ID card holders in the Granite State have been waiting to legally buy medical marijuana, and will continue waiting until springtime — when New Hampshire's first dispensaries are expected to open. 

If you are a first-time visitor, please be sure to like us on Facebook and receive our exciting and innovative tutorials on health topics and natural remedies.

One of the latest studies proves how the oral use of cannabis in the form of ‘hemp oil’ can be amazingly helpful in treating leukemia and various cancer types. A young teenage girl diagnosed with acute lymphoblastic leukemia and Philadelphia chromosome mutation was subject to this study.

A purified compound derived from marijuana may help reduce seizures in children and young adults with severe forms of epilepsy that resist other treatments, a new study suggests.

Patients who added a 99 percent-cannabidiol (CBD) oil to their current treatments went from an average of 30 seizures a month to fewer than 16 - representing a 37 percent reduction over 12 weeks, researchers report in Lancet Neurology.

"In this group that has been extremely treatment resistant, this was an incredibly positive finding with the caveat that we didn't have a comparison group," said lead author Dr. Orrin Devinsky, of NYU Langone Medical Center in New York City.